Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. Net Income 2023–2025
Entrada Therapeutics Inc. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Entrada Therapeutics Inc. net income for the quarter ending March 31, 2026 was -39.7 M, a 128.93% increase year-over-year.
- Entrada Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -144.3 M, a 244.37% decrease year-over-year.
- Entrada Therapeutics Inc. annual net income for 2025 was -143.8 M, a 319.04% decrease from 2024.
- Entrada Therapeutics Inc. annual net income for 2024 was 65.6 M, a 1081.69% decrease from 2023.
- Entrada Therapeutics Inc. annual net income for 2023 was -6.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Entrada Therapeutics Inc. Net Income — FAQ
Entrada Therapeutics Inc. (TRDA) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Entrada Therapeutics Inc.'s net income?
Entrada Therapeutics Inc. (TRDA) reported net income of -$144M for fiscal 2025.
Where can I see TRDA's net income history?
The chart and table above show Entrada Therapeutics Inc.'s net income by year and by quarter, including the growth rate.